Phoenix Biotechnology Secures $1,120,600 New Financing

  • Feed Type
  • Date
    9/12/2010
  • Company Name
    Phoenix Biotechnology
  • Mailing Address
    8626 Tesoro Dr. San Antonio, TX 78217
  • Company Description
    The company was created through the acquisition of the assets of Anvirlat, Inc., a privately held Nevada corporation controlled by Messrs. Addington and Kost, current officers and directors of the company. Company research has led to the development of an anti-neoplastic agent that the company has entered into USFDA Phase I Clinical Trials in 2007.
  • Website
    http://www.phoenixbiotechnology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,120,600
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy